NEWS
-
October 10, 2024
EP-PharmaLine is a proud recipient of Contact Center Awards 2024 "Jury‘s Special Award".
EP-PharmaLine received the Jury‘s Special Award at the Contact Center Awards 2024, hosted by Rick Telecom Co., Ltd. and the editorial department of Call Center Japan.
Awards -
July 1, 2024
Notice of Fukuoka Office Relocation
As of July 1, 2024, EP-PharmaLine's Fukuoka office has relocated to the following address :
Taihaku Center Building 6F, 2-19-24 Hakata-ekimae Hakata-ku, Fukuoka City, Fukuoka 812-0011, Japan Profile -
May 14, 2024
Announcement of Feature in Pharma Tech Outlook "Vendor Viewpoints"
EP-PharmaLine has been featured in the "Vendor Viewpoint" section of Pharma Tech Outlook.
Awards
【Vendor Viewpoints: The Strength of EP-PharmaLine in Adapting to Japan’s medical Industry】 https://pharma-consulting-apac.pharmatechoutlook.com/vp/-ep-pharmaline/the_strength_of_ep-pharmaline_in_adapting_to_japan's_unique_medical_industry/
EP-PharmaLine Highlight
-
1,440
Employees
-
1,065
Licensed Employees
(Pharmacists, Nurses, MR, National registered dietitians, Dietitians, Veterinarian, Registered salesperson of OTC drugs, Medical Technologist, Clinical Engineer etc.) -
300+
Clients
-
25+
years of experience
*as of Oct. 2024
Transactions within Japan in 2024
800+
Number of contracts
From pharmaceutical, medical device, and healthcare companies
Number of companies contracted for
Medical Contact Center Service: About 80
Medical Affairs Service: 70+
(Creation and Revision of Promotional Materials Support Service, Regulation Review Related Service)
BPO Service: About 40
(PMS support service, Drug Distribution Management Support Service, etc. )
Medical Device Contact Center Service: About 30
Healthcare Support Service: 25+, etc.
Number of subscribers
to pharmaceutical, medical device, and healthcare companies
Award Experience
- 2022 Best Operation Award, Contact Center Award
- 2023 Jury's Special Award, Contact Center Award
- Top Pharma Consulting Company in Japan 2023 awarded by Pharma Tech Outlook, etc. For more details, click here